We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

81 hedge funds and large institutions have $158M invested in Fortress Biotech in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

290% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 10

264% more call options, than puts

Call options by funds: $20.3M | Put options by funds: $5.59M

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

19% more funds holding

Funds holding: 68 → 81 (+13)

12% more capital invested

Capital invested by funds: $141M → $158M (+$17.4M)

Holders
81
Holders Change
+13
Holders Change %
+19.12%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
39
Reduced
10
Closed
6
Calls
$20.3M
Puts
$5.59M
Net Calls
+$14.8M
Net Calls Change
+$13.9M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.9M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$11.3M
3
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$6.33M
4
CWAM
Columbia Wanger Asset Management
Illinois
+$4.29M
5
CIP
Chartwell Investment Partners
Pennsylvania
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$3.74M
2
SCM
Suffolk Capital Management
New York
-$3.21M
3
SC
Sophrosyne Capital
New York
-$1.59M
4
PC
PointState Capital
New York
-$1.32M
5
MCM
Montibus Capital Management
Oregon
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$35.3M +$11.9M +96,734 +41%
EM
2
Elliott Management
New York
$26.2M – – –
CWAM
3
Columbia Wanger Asset Management
Illinois
$13.5M +$4.29M +35,000 +38%
Jennison Associates
4
Jennison Associates
New York
$11.5M +$3.39M +27,649 +34%
AllianceBernstein
5
AllianceBernstein
Tennessee
$9.79M +$11.3M +92,320 +14,225%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$8.3M +$194K +1,580 +2%
BCPEM
7
Bain Capital Public Equity Management
Massachusetts
$5.43M +$6.33M +51,667 New
BFA
8
BlackRock Fund Advisors
California
$5.03M +$1.37M +11,180 +31%
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.52M +$133K +1,087 +3%
CIP
10
Chartwell Investment Partners
Pennsylvania
$3.46M +$4.04M +32,921 New
Goldman Sachs
11
Goldman Sachs
New York
$2.89M +$3.37M +27,469 New
SCA
12
SAC Capital Advisors
Connecticut
$2.83M +$3.29M +26,847 New
MCM
13
Montibus Capital Management
Oregon
$2.74M -$329K -2,685 -9%
Northern Trust
14
Northern Trust
Illinois
$2.4M +$528K +4,308 +23%
BIT
15
BlackRock Institutional Trust
California
$2.37M +$812K +6,627 +42%
State Street
16
State Street
Massachusetts
$2M +$134K +1,092 +6%
ACM
17
Advent Capital Management
New York
$1.42M +$1.41M +11,460 +573%
MOACM
18
Mutual of America Capital Management
New York
$1.35M +$764K +6,232 +94%
Millennium Management
19
Millennium Management
New York
$1.25M +$851K +6,945 +142%
Bank of America
20
Bank of America
North Carolina
$1.18M +$809K +6,599 +142%
Allianz Asset Management
21
Allianz Asset Management
Germany
$1.16M +$145K +1,186 +12%
OAM
22
Oxford Asset Management
United Kingdom
$1.07M +$1.24M +10,128 New
Ameriprise
23
Ameriprise
Minnesota
$910K +$361K +2,947 +52%
TCIM
24
TIAA CREF Investment Management
New York
$882K +$28.8K +235 +3%
FCM
25
Farallon Capital Management
California
$824K – – –
1
2 3 4

FBIO Hedge Fund Activity: Q3 2013 in Review

81 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2013, worth a combined $158M — up 12% from $141M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FBIO positions and 6 closed out — a net gain of 13 holders — while 39 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $11.9M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.74M sold.

  • 81 institutional investors held Fortress Biotech (FBIO) as of Q3 2013, up from 68 in Q2 2013.
  • Funds reported $158M of Fortress Biotech stock for Q3 2013, up 12% quarter-over-quarter.
  • 19 funds opened new Fortress Biotech positions in Q3 2013 and 6 closed out, a net change of +13 holders.
  • The largest Fortress Biotech buyer in Q3 2013 was Fidelity Investments, an estimated $11.9M added.
  • The largest Fortress Biotech seller in Q3 2013 was Driehaus Capital Management, an estimated $3.74M sold.

Based on aggregated 13F filings for Q3 2013.